PharmAla saw a significant slowdown in our SAP revenue as we transitioned to our new distribution partner, Rane Pharma. However, this was counterbalanced by very strong growth in our Clinical Trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback